3 completed, 1 active not recruiting, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Active not recruiting 1, Terminated 1 |
Follow Lispro: new trials by email Literature Review of Lispro trials Research Report on Lispro
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec HDV-Lispro, Lispro - Diabetes Mellitus, Type 1 | Phase 2 | Completed | Diasome Pharmaceuticals | 227 | 2023-12-28 | 2026-07-31 |
| Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes Sliding Scale Insulin, Up-Titration of Home Insulin, Continuous Insulin Infusion - Diabetes Mellitus, Type 2, Preterm Birth | Phase 2 | Active not recruiting | University of Alabama at Birmingham | 120 | 2022-02-10 | 2026-07-14 |
| PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD inhaled human insulin, Insulin Lispro (Humalog U-100) - Safety and Tolerability | Phase 2 | Terminated | Dance Biopharm Inc. | 40 | 2018-02-06 | 2019-09-13 |
| Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus Insulin lispro, Insulin aspart, Recombinant human hyaluronidase PH20 - Diabetes Mellitus, Type II | Phase 2 | Completed | Halozyme Therapeutics | 132 | 2010-08-01 | 2014-08-20 |
| A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro Regular Human Insulin, Lispro, VIAject - Diabetes Mellitus | Phase 2 | Completed | Biodel | 24 | 2006-06-01 | 2015-07-29 |
Diabetes Mellitus, Type 2 (2) · Asthma (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Diabetes, Gestational (1) · Premature Birth (1) · Pulmonary Disease, Chronic Obstructive (1)
Biodel (1) · Dance Biopharm Inc. (1) · Diasome Pharmaceuticals (1) · Halozyme Therapeutics (1) · University of Alabama at Birmingham (1)
United States (5)
Ashley N Battarbee, MD (1) · Douglas Muchmore, M.D. (1) · Marcus Hompesch, MD (1) · Ruth Weinstock, MD (1) · Timothy S Bailey, MD (1)
K23HD103875 (1)